Professor Luke O'Neill

But...

roll of drums now is needed.

Literally in the last few days, a new drug has been approved that blocks IL-23, but it's a tablet.

Now the current Skyrizzy type drug, Orcocentix, they're injectable.

This is orally active.

You can take it as a tablet and this will block IL-23.

It's the first drug orally active that really stops psoriasis.

So it's a big fanfare.

for the world of psoriasis.

It's got the name Icotide.

It's made by Johnson & Johnson.

It's also called Icotroquinra, but the trade name is Icotide and that got approved by the FDA in America.

I don't think it's available in Ireland yet, but certainly the US has approved this new.

We'll come here for definite.

Here's a tablet you can take.

Incredibly.

And they were getting 70% response.

in severe psoriasis, which is great.

That means 70% of the skin is cleared, which is a big effect in this severe disease.

So really, I guess what I'm saying is, great example, an autoimmune disease, mysterious, it's in the skin, we don't know what causes it.